Anti-Spastic Splint With Focal Muscle Vibration for Stroke Hand Spasticity
NCT ID: NCT06358976
Last Updated: 2024-04-15
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
NOT_YET_RECRUITING
Clinical Phase
NA
Total Enrollment
48 participants
Study Classification
INTERVENTIONAL
Study Start Date
2024-08-01
Study Completion Date
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Title: The Effect of Vibrating Splint on Hand Function After Stroke
Summary:
This study aims to investigate the effectiveness of a vibrating splint in improving hand function and reducing spasticity among individuals who have experienced a stroke. Stroke is a major global health issue, often resulting in long-term disability and impairments in the upper limbs. Spasticity, a common complication of stroke, causes stiffness and involuntary muscle contractions, leading to difficulties in performing daily activities.
Current treatment options for spasticity include medications and physical therapy techniques. However, these approaches may have limitations in terms of effectiveness and duration of benefits. Therefore, non-pharmacological interventions are being explored to enhance rehabilitation outcomes.
The hypothesis of this study is that the use of a vibrating splint, which applies mechanical vibrations to the hand muscles, will decrease spasticity and improve hand functionality in individuals with chronic stroke. The vibrations from the splint stimulate the sensory receptors in the skin and muscles, leading to muscle relaxation and improved motor control.
The study will be conducted as a pilot randomized controlled trial, involving participants who meet specific eligibility criteria. The participants will be divided into three arms, with each arm receiving a different intervention. Outcome measures, including assessments of spasticity, range of motion, pain levels, and functional abilities, will be collected before and after the intervention period.
The findings from this study will contribute to the understanding of non-pharmacological approaches in managing spasticity and improving hand function after stroke. If the vibrating splint proves to be effective, it could offer a safe and accessible option for stroke survivors to enhance their recovery and regain independence in daily activities.
This research is essential as it addresses the need for more effective interventions for spasticity management and hand rehabilitation after stroke. By providing valuable insights into the potential benefits of the vibrating splint, this study has the potential to improve the quality of life for individuals who have experienced a stroke and empower them to regain control over their hand movements.
Summary:
This study aims to investigate the effectiveness of a vibrating splint in improving hand function and reducing spasticity among individuals who have experienced a stroke. Stroke is a major global health issue, often resulting in long-term disability and impairments in the upper limbs. Spasticity, a common complication of stroke, causes stiffness and involuntary muscle contractions, leading to difficulties in performing daily activities.
Current treatment options for spasticity include medications and physical therapy techniques. However, these approaches may have limitations in terms of effectiveness and duration of benefits. Therefore, non-pharmacological interventions are being explored to enhance rehabilitation outcomes.
The hypothesis of this study is that the use of a vibrating splint, which applies mechanical vibrations to the hand muscles, will decrease spasticity and improve hand functionality in individuals with chronic stroke. The vibrations from the splint stimulate the sensory receptors in the skin and muscles, leading to muscle relaxation and improved motor control.
The study will be conducted as a pilot randomized controlled trial, involving participants who meet specific eligibility criteria. The participants will be divided into three arms, with each arm receiving a different intervention. Outcome measures, including assessments of spasticity, range of motion, pain levels, and functional abilities, will be collected before and after the intervention period.
The findings from this study will contribute to the understanding of non-pharmacological approaches in managing spasticity and improving hand function after stroke. If the vibrating splint proves to be effective, it could offer a safe and accessible option for stroke survivors to enhance their recovery and regain independence in daily activities.
This research is essential as it addresses the need for more effective interventions for spasticity management and hand rehabilitation after stroke. By providing valuable insights into the potential benefits of the vibrating splint, this study has the potential to improve the quality of life for individuals who have experienced a stroke and empower them to regain control over their hand movements.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Passive Tactile Stimulation for Stroke Rehabilitation
NCT03814889
Stroke
Stroke, Ischemic
Stroke Hemorrhagic
+1 more
COMPLETED
NA
Effects of Focal Muscle Vibration Versus Whole Upper Limb Vibration in Post-Stroke Patients
NCT07340034
Stroke
Post Stroke Upper Limb Spasticity
NOT_YET_RECRUITING
NA
Focal Muscular Vibration to Treat Upper Limb Spasticity in Stroke
NCT04087928
Stroke
COMPLETED
NA
Repeated Muscle Vibration in Acute Stroke
NCT03697525
Acute Stroke
COMPLETED
NA
Evaluation of Vibration-based Wearable Upper Limb Rehabilitation Device
NCT04698369
Stroke
TERMINATED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This pilot randomized controlled trial (RCT) aims to assess the clinical effectiveness and efficacy of adding focal muscle vibration (FMV) to anti-spastic splint therapy for individuals with spasticity following a stroke. The study involves multiple centers in the Jenin area of Palestine, utilizing outpatient rehabilitation centers to recruit participants who have chronic spasticity post-stroke.
Study Objectives and Questions:
Determine whether adding FMV to anti-spastic splint therapy provides additional benefit for individuals with spasticity after a stroke.
Compare the outcomes of anti-spastic splint therapy, FMV therapy, and a combination of both interventions in individuals with post-stroke spasticity.
Explore participant perceptions regarding the effectiveness, acceptability, and adherence to the interventions.
Study Design and Procedures:
The study is a pilot, multi-center RCT with a single evaluator (evaluator-blind) approach to avoid bias.
Forty-eight participants will be randomly assigned to one of three groups: Arm 1 (anti-spastic splint and FMV), Arm 2 (FMV only), or Arm 3 (anti-spastic splint only).
Interventions will be delivered by trained rehabilitation specialists, including occupational and physical therapists.
Standardized intervention protocols will guide the delivery of FMV and anti-spastic splint therapy for a period of four weeks.
Participant Recruitment:
Participants with chronic post-stroke spasticity are recruited from multiple rehabilitation centers and screened based on specific inclusion and exclusion criteria.
Convenience sampling is used to enroll participants from available populations in the participating centers.
Data Collection and Management:
Baseline and post-treatment evaluations include measurements of spasticity, hand functionality, range of motion, and pain level.
Qualitative interviews will explore participants' experiences with the interventions and their perceptions of the treatments' effectiveness.
Data will be securely stored and anonymized to protect participants' privacy.
Statistical Analysis Plan:
Linear Mixed-Effects Models (LMEM) will be used to assess treatment effects, adjusting for correlation over time within participants.
The safety analysis will involve documenting and summarizing adverse events (AEs) across treatment groups.
The study aims to provide preliminary data on treatment effects and inform the design of future larger RCTs.
Study Objectives and Questions:
Determine whether adding FMV to anti-spastic splint therapy provides additional benefit for individuals with spasticity after a stroke.
Compare the outcomes of anti-spastic splint therapy, FMV therapy, and a combination of both interventions in individuals with post-stroke spasticity.
Explore participant perceptions regarding the effectiveness, acceptability, and adherence to the interventions.
Study Design and Procedures:
The study is a pilot, multi-center RCT with a single evaluator (evaluator-blind) approach to avoid bias.
Forty-eight participants will be randomly assigned to one of three groups: Arm 1 (anti-spastic splint and FMV), Arm 2 (FMV only), or Arm 3 (anti-spastic splint only).
Interventions will be delivered by trained rehabilitation specialists, including occupational and physical therapists.
Standardized intervention protocols will guide the delivery of FMV and anti-spastic splint therapy for a period of four weeks.
Participant Recruitment:
Participants with chronic post-stroke spasticity are recruited from multiple rehabilitation centers and screened based on specific inclusion and exclusion criteria.
Convenience sampling is used to enroll participants from available populations in the participating centers.
Data Collection and Management:
Baseline and post-treatment evaluations include measurements of spasticity, hand functionality, range of motion, and pain level.
Qualitative interviews will explore participants' experiences with the interventions and their perceptions of the treatments' effectiveness.
Data will be securely stored and anonymized to protect participants' privacy.
Statistical Analysis Plan:
Linear Mixed-Effects Models (LMEM) will be used to assess treatment effects, adjusting for correlation over time within participants.
The safety analysis will involve documenting and summarizing adverse events (AEs) across treatment groups.
The study aims to provide preliminary data on treatment effects and inform the design of future larger RCTs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Spasticity as Sequela of Stroke
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
FACTORIAL
The interventional study model for this clinical study is a pilot randomized controlled trial. Participants will be randomly assigned to one of three arms: Group A (vibrating splint intervention), Group B (standard splint intervention), or Group C (control group receiving no splint intervention). This model allows for the comparison of different interventions and the evaluation of their effectiveness in improving hand function and reducing spasticity after stroke. Randomization helps ensure that each group is comparable in terms of baseline characteristics, minimizing bias and increasing the validity of the study results.
Primary Study Purpose
OTHER
Blinding Strategy
SINGLE
Investigators
In this clinical trial, due to the nature of the interventions, it may not be possible to mask or blind the participants or therapists to the treatment received. However, efforts will be made to blind the outcome assessors who will be responsible for evaluating the participants' hand function, spasticity, and other outcome measures. Blinding the outcome assessors helps minimize potential bias and ensures the objective assessment of the intervention's effectiveness. By keeping the assessors unaware of the participants' group allocations, the integrity and reliability of the study findings can be enhanced.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vibration plus anti-spastic hand splint Arm
In this clinical trial, vibration stimulation will be applied to the spastic hand antagonistic muscles using a specific device consisting of a volar anti-spastic hand splint and the arm vibrator. The volar anti-spastic hand splint will be custom-made for each participant at the prosthetic and orthotic clinic, following a standardized protocol. The arm vibrator, designed to fit the arm, will deliver the required vibration parameters. The intervention protocol involves a 30-minute vibration session administered three times weekly for four weeks, accompanied by daily utilization of the custom-made splint for 30 minutes each day.
Group Type
EXPERIMENTAL
Vibration plus anti-spastic hand splint
Intervention Type
OTHER
vibration stimulation will be applied to the spastic hand antagonistic muscles using a volar anti-spastic hand splint and the Myovolt Arm vibrator.
Anti-spastic hand splint Arm
In the anti-spastic hand splint arm , participants will be provided with an anti-spastic splint without vibration. Both vibration plus anti-spastic hand splint arm and anti-spastic hand splint arm will adhere to the same splint standard regime and recommendations, which outlines the specific positioning for the splint.
Group Type
ACTIVE_COMPARATOR
Anti-spastic hand splint
Intervention Type
OTHER
the use of anti-spastic hand splint alone.
Vibration Arm
In vibration arm , participants will be provided with arm vibrator held in place by appropriate padded harness. A Standardized study protocol will be used each time with no splint.
Group Type
ACTIVE_COMPARATOR
Vibration
Intervention Type
OTHER
The use of hand vibrator alone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vibration plus anti-spastic hand splint
vibration stimulation will be applied to the spastic hand antagonistic muscles using a volar anti-spastic hand splint and the Myovolt Arm vibrator.
Intervention Type
OTHER
Anti-spastic hand splint
the use of anti-spastic hand splint alone.
Intervention Type
OTHER
Vibration
The use of hand vibrator alone
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals affected by chronic (more than one year) spastic ischemic or hemorrhagic stroke
* Aged above 18 years old
* Medically stable (has no cardiovascular event in the last 12 months)
* A score of 1-4 on modified Ashworth scale.
* Aged above 18 years old
* Medically stable (has no cardiovascular event in the last 12 months)
* A score of 1-4 on modified Ashworth scale.
Exclusion Criteria
* Cardiovascular event in the past 12 months
* Received anti-spastic injections drugs into the affected hand in the last 6 months
* A score of less than 21 on Rowland Universal Dementia Assessment Scale (RUDAS)
* Upper limb and trunk musculoskeletal injuries
* A score of 0 on modified Ashworth scale.
* Received anti-spastic injections drugs into the affected hand in the last 6 months
* A score of less than 21 on Rowland Universal Dementia Assessment Scale (RUDAS)
* Upper limb and trunk musculoskeletal injuries
* A score of 0 on modified Ashworth scale.
Minimum Eligible Age
18 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arab American University (Palestine)
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amer Jaroshy
Principal Investigator
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hisham Arab Alkabeya, PhD
Role: STUDY_CHAIR
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arab American University
Jenin, , Palestinian Territories
Site Status
Countries
Review the countries where the study has at least one active or historical site.
Palestinian Territories
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Tedla JS, Gular K, Reddy RS, de Sa Ferreira A, Rodrigues EC, Kakaraparthi VN, Gyer G, Sangadala DR, Qasheesh M, Kovela RK, Nambi G. Effectiveness of Constraint-Induced Movement Therapy (CIMT) on Balance and Functional Mobility in the Stroke Population: A Systematic Review and Meta-Analysis. Healthcare (Basel). 2022 Mar 8;10(3):495. doi: 10.3390/healthcare10030495.
Reference Type
BACKGROUND
Alashram AR, Padua E, Romagnoli C, Annino G. Effectiveness of focal muscle vibration on hemiplegic upper extremity spasticity in individuals with stroke: A systematic review. NeuroRehabilitation. 2019 Dec 18;45(4):471-481. doi: 10.3233/NRE-192863.
Reference Type
BACKGROUND
Alghadir AH, Anwer S, Iqbal ZA. The psychometric properties of an Arabic numeric pain rating scale for measuring osteoarthritis knee pain. Disabil Rehabil. 2016 Dec;38(24):2392-7. doi: 10.3109/09638288.2015.1129441. Epub 2016 Jan 6.
Reference Type
BACKGROUND
Amatya B, Khan F, La Mantia L, Demetrios M, Wade DT. Non pharmacological interventions for spasticity in multiple sclerosis. Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD009974. doi: 10.1002/14651858.CD009974.pub2.
Reference Type
BACKGROUND
Andringa A, van de Port I, Meijer JW. Long-term use of a static hand-wrist orthosis in chronic stroke patients: a pilot study. Stroke Res Treat. 2013;2013:546093. doi: 10.1155/2013/546093. Epub 2013 Feb 27.
Reference Type
BACKGROUND
Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010 Jul 16;10:67. doi: 10.1186/1471-2288-10-67.
Reference Type
BACKGROUND
Beebe JA, Lang CE. Active range of motion predicts upper extremity function 3 months after stroke. Stroke. 2009 May;40(5):1772-9. doi: 10.1161/STROKEAHA.108.536763. Epub 2009 Mar 5.
Reference Type
BACKGROUND
Davis EC, Barnes MP. Botulinum toxin and spasticity. J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):143-7. doi: 10.1136/jnnp.69.2.143. No abstract available.
Reference Type
BACKGROUND
de Jong LD, Dijkstra PU, Stewart RE, Postema K. Repeated measurements of arm joint passive range of motion after stroke: interobserver reliability and sources of variation. Phys Ther. 2012 Aug;92(8):1027-35. doi: 10.2522/ptj.20110280. Epub 2012 May 10.
Reference Type
BACKGROUND
Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL, Bond CM. Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework. PLoS One. 2016 Mar 15;11(3):e0150205. doi: 10.1371/journal.pone.0150205. eCollection 2016.
Reference Type
BACKGROUND
Elfil M, Negida A. Sampling methods in Clinical Research; an Educational Review. Emerg (Tehran). 2017;5(1):e52. Epub 2017 Jan 14.
Reference Type
BACKGROUND
Fattorini L, Ferraresi A, Rodio A, Azzena GB, Filippi GM. Motor performance changes induced by muscle vibration. Eur J Appl Physiol. 2006 Sep;98(1):79-87. doi: 10.1007/s00421-006-0250-5. Epub 2006 Aug 9.
Reference Type
BACKGROUND
Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014 Jan 18;383(9913):245-54. doi: 10.1016/s0140-6736(13)61953-4.
Reference Type
BACKGROUND
Francisco GE, McGuire JR. Poststroke spasticity management. Stroke. 2012 Nov;43(11):3132-6. doi: 10.1161/STROKEAHA.111.639831. Epub 2012 Sep 13. No abstract available.
Reference Type
BACKGROUND
Gregson JM, Leathley M, Moore AP, Sharma AK, Smith TL, Watkins CL. Reliability of the Tone Assessment Scale and the modified Ashworth scale as clinical tools for assessing poststroke spasticity. Arch Phys Med Rehabil. 1999 Sep;80(9):1013-6. doi: 10.1016/s0003-9993(99)90053-9.
Reference Type
BACKGROUND
Hernandez ED, Galeano CP, Barbosa NE, Forero SM, Nordin A, Sunnerhagen KS, Alt Murphy M. Intra- and inter-rater reliability of Fugl-Meyer Assessment of Upper Extremity in stroke. J Rehabil Med. 2019 Oct 4;51(9):652-659. doi: 10.2340/16501977-2590.
Reference Type
BACKGROUND
Katan M, Luft A. Global Burden of Stroke. Semin Neurol. 2018 Apr;38(2):208-211. doi: 10.1055/s-0038-1649503. Epub 2018 May 23.
Reference Type
BACKGROUND
Kerr L, Jewell VD, Jensen L. Stretching and Splinting Interventions for Poststroke Spasticity, Hand Function, and Functional Tasks: A Systematic Review. Am J Occup Ther. 2020 Sep/Oct;74(5):7405205050p1-7405205050p15. doi: 10.5014/ajot.2020.029454.
Reference Type
BACKGROUND
Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004 May;10(2):307-12. doi: 10.1111/j..2002.384.doc.x.
Reference Type
BACKGROUND
Lannin NA, Herbert RD. Is hand splinting effective for adults following stroke? A systematic review and methodologic critique of published research. Clin Rehabil. 2003 Dec;17(8):807-16. doi: 10.1191/0269215503cr682oa.
Reference Type
BACKGROUND
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053. No abstract available.
Reference Type
BACKGROUND
Nam KE, Lim SH, Kim JS, Hong BY, Jung HY, Lee JK, Yoo SD, Pyun SB, Lee KM, Lee KJ, Kim H, Han EY, Lee KW. When does spasticity in the upper limb develop after a first stroke? A nationwide observational study on 861 stroke patients. J Clin Neurosci. 2019 Aug;66:144-148. doi: 10.1016/j.jocn.2019.04.034. Epub 2019 May 11.
Reference Type
BACKGROUND
Noma T, Matsumoto S, Shimodozono M, Etoh S, Kawahira K. Anti-spastic effects of the direct application of vibratory stimuli to the spastic muscles of hemiplegic limbs in post-stroke patients: a proof-of-principle study. J Rehabil Med. 2012 Apr;44(4):325-30. doi: 10.2340/16501977-0946.
Reference Type
BACKGROUND
Pathak A, Gyanpuri V, Dev P, Dhiman NR. The Bobath Concept (NDT) as rehabilitation in stroke patients: A systematic review. J Family Med Prim Care. 2021 Nov;10(11):3983-3990. doi: 10.4103/jfmpc.jfmpc_528_21. Epub 2021 Nov 29.
Reference Type
BACKGROUND
Phadke CP, Balasubramanian CK, Ismail F, Boulias C. Revisiting physiologic and psychologic triggers that increase spasticity. Am J Phys Med Rehabil. 2013 Apr;92(4):357-69. doi: 10.1097/phm.0b013e31827d68a4.
Reference Type
BACKGROUND
Poenaru D, Cinteza D, Petrusca I, Cioc L, Dumitrascu D. Local Application of Vibration in Motor Rehabilitation - Scientific and Practical Considerations. Maedica (Bucur). 2016 Sep;11(3):227-231.
Reference Type
BACKGROUND
Shiner CT, Vratsistas-Curto A, Bramah V, Faux SG, Watanabe Y. Prevalence of upper-limb spasticity and its impact on care among nursing home residents with prior stroke. Disabil Rehabil. 2020 Jul;42(15):2170-2177. doi: 10.1080/09638288.2018.1555620. Epub 2019 Mar 31.
Reference Type
BACKGROUND
Sommerfeld DK, Eek EU, Svensson AK, Holmqvist LW, von Arbin MH. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke. 2004 Jan;35(1):134-9. doi: 10.1161/01.STR.0000105386.05173.5E. Epub 2003 Dec 18.
Reference Type
BACKGROUND
Suputtitada A, Chatromyen S, Chen CPC, Simpson DM. Best Practice Guidelines for the Management of Patients with Post-Stroke Spasticity: A Modified Scoping Review. Toxins (Basel). 2024 Feb 10;16(2):98. doi: 10.3390/toxins16020098.
Reference Type
BACKGROUND
Suresh K, Thomas SV, Suresh G. Design, data analysis and sampling techniques for clinical research. Ann Indian Acad Neurol. 2011 Oct;14(4):287-90. doi: 10.4103/0972-2327.91951.
Reference Type
BACKGROUND
Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, Robson R, Thabane M, Giangregorio L, Goldsmith CH. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010 Jan 6;10:1. doi: 10.1186/1471-2288-10-1.
Reference Type
BACKGROUND
Welmer AK, Widen Holmqvist L, Sommerfeld DK. Location and severity of spasticity in the first 1-2 weeks and at 3 and 18 months after stroke. Eur J Neurol. 2010 May;17(5):720-5. doi: 10.1111/j.1468-1331.2009.02915.x. Epub 2009 Dec 29.
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Spasticity splint and FMV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Focal Muscle Vibrations in Acute Stroke
NCT06793566
WITHDRAWN
NA
Relationship Between Upper Extremity' Viscoelastic Properties and Functionality in Subacute Stroke
NCT05920837
UNKNOWN
Vibration Stimuli in Stroke Patients With Contraversive Pusher Syndrome
NCT02824900
WITHDRAWN
NA
Use of Sensory Substitution to Improve Arm Control After Stroke
NCT03298243
RECRUITING
NA
Robotically Augmented Mental Practice
NCT04962698
COMPLETED
NA
The Effects of Muscle Vibration on the Development of Spasticity and Neuroplasticity in a Post-stroke Population
NCT05315726
RECRUITING
NA
Effects of Vibration on Motor Function of Survivors of Chronic Stroke
NCT06663501
RECRUITING
NA
Spinal Plasticity to Enhance Motor Retraining After Stroke
NCT03645122
COMPLETED
NA
Wearable Robotic System and Robotic Mirror Therapy in Spastic Hemiplegia Post Botulinum Toxin Injection
NCT04826900
COMPLETED
NA
Effectiveness of WBV Versus RAS on Spasticity, Balance, and Lower Limb Motor Function on Hemiplegic Stroke Patients
NCT06567223
ACTIVE_NOT_RECRUITING
NA
Neuroplasticity With Daily Use of a Sensorimotor Priming Vibration System to Improve Hand Function After Stroke
NCT04026399
COMPLETED
NA
Concomitant Sensory Stimulation During Therapy to Enhance Hand Functional Recovery Post Stroke
NCT04569123
COMPLETED
NA
Effectiveness of Robot-assisted Rehabilitation in Persons With Stroke
NCT04002076
UNKNOWN
NA
Combined Antagonistic Muscle Magnetic Stimulation and Selective Periferal Neurotomy to Improve Results on Spasticity
NCT02226432
NOT_YET_RECRUITING
NA
Tendon Vibrations Effect on Upper Limb Motor Recovery After Recent Stroke
NCT04504214
UNKNOWN
NA
Effects of Whole-body Vibration Exercise on Stroke Patients
NCT03375346
COMPLETED
NA
The Efficacy of Dynamic Hand Splint Treatment in Spastic Hemiparetic Patients
NCT04441437
COMPLETED
NA
Study of Hand Therapy 3 to 24 Months After Stroke
NCT00435617
COMPLETED
NA
VIBROACOUSTIC THERAPY in PATIENTS WITH STROKE
NCT07206485
NOT_YET_RECRUITING
NA
Positioning the Trunk and Upper Limb to Improve the Coordination of the Hand Movement After Stroke
NCT04782141
COMPLETED
NA
Mechanism of Action of Focal Extracorporeal Shock Waves as a Treatment of Upper Limb Stroke Spasticity: a Pilot Study
NCT06311526
COMPLETED
Effect of Verbal Instruction on Pelvic Floor Muscle Contraction in Post Stroke Patients
NCT03903627
COMPLETED
NA
Effects of Low Level Laser Therapy on Wrist Flexors Spasticity and Hand Functions in Patients With Stroke
NCT07171788
NOT_YET_RECRUITING
NA
Brain and Coordination Changes Induced By Robotics and FES Treatment Following Stroke
NCT00237744
COMPLETED
NA